Medical Posters

RSS

Monitoring air pollution-induced inflammation through breath VOC biomarkers

Monitoring air pollution-induced inflammation through breath VOC biomarkers

Breath VOC biomarkers provide a non-invasive tool to monitor inflammation triggered by air pollution.

From Owlstone Medical Ltd 15 Jul 2025

Targeted breath biomarker analysis of VOCs using TD-GC-MS

Targeted breath biomarker analysis of VOCs using TD-GC-MS

Explore how TD-GC-MS enables targeted breath biomarker analysis of volatile organic compound biomarkers in human breath.

From Owlstone Medical Ltd 15 Jul 2025

Tracking intestinal methanogen activity with longitudinal breath testing

Tracking intestinal methanogen activity with longitudinal breath testing

Longitudinal breath testing offers a non-invasive way to monitor intestinal methanogen activity.

From Owlstone Medical Ltd 15 Jul 2025

Breath-based biomarker discovery for asthma with the VOC Atlas

Breath-based biomarker discovery for asthma with the VOC Atlas

Discover how the VOC Atlas supports breath-based biomarker discovery for asthma.

From Owlstone Medical Ltd 15 Jul 2025

How multi-laser picodroplet technology can help with single cell analysis

How multi-laser picodroplet technology can help with single cell analysis

Discover how multi-laser picodroplet is a critical tool for high-throughput single cell analysis.

From Fluidic Sciences and Sphere Bio 5 Jun 2025

Scalable human iPSC-derived retinal organoids for in vitro toxicology

Scalable human iPSC-derived retinal organoids for in vitro toxicology

With rising cases of untreatable retinal degeneration, there's a critical need for human-relevant retinal organoid models.

From Newcells Biotech 28 Mar 2025

Scalable human iPSC retinal organoids

Scalable human iPSC retinal organoids

Retinal organoids offer powerful insights into vision science and drug discovery.

From Newcells Biotech 28 Mar 2025

Advancing in vitro assays to model fibroblast-to-myofibroblast transition in fibrosis

Advancing in vitro assays to model fibroblast-to-myofibroblast transition in fibrosis

This study addresses technical challenges in modeling TGF-β1-induced fibroblast activation and FMT in vitro.

From Newcells Biotech 28 Mar 2025

Modeling EMT and FMT in lung fibrosis using high-content imaging for drug discovery

Modeling EMT and FMT in lung fibrosis using high-content imaging for drug discovery

Explore how high-content imaging enables in vitro modeling of key fibrotic processes—EMT and FMT—in lung disease.

From Newcells Biotech 28 Mar 2025

High-content imaging assay for fibroblast activation and matrix deposition in pulmonary fibrosis

High-content imaging assay for fibroblast activation and matrix deposition in pulmonary fibrosis

This in vitro assay models key features of idiopathic pulmonary fibrosis (IPF), including fibroblast activation and ECM deposition.

From Newcells Biotech 28 Mar 2025

High-content imaging enables in vitro modeling of lung fibrosis for anti-fibrotic drug discovery

High-content imaging enables in vitro modeling of lung fibrosis for anti-fibrotic drug discovery

Chronic epithelial injury and TGF-β1-driven fibroblast-to-myofibroblast transition contribute to lung fibrosis.

From Newcells Biotech 28 Mar 2025

In vitro modeling of small airway epithelium for studying barrier function and mucociliary clearance

In vitro modeling of small airway epithelium for studying barrier function and mucociliary clearance

Small airways are critical in respiratory defense and disease but remain hard to study in vivo.

From Newcells Biotech 28 Mar 2025

Evaluating consistency in large-scale human iPSC retinal organoids

Evaluating consistency in large-scale human iPSC retinal organoids

To overcome limitations of current retinal models, discover gene and protein marker expression in large-scale human iPSC-derived retinal organoids.

From Newcells Biotech 28 Mar 2025

Exploring cerebral and cardiac organoids

Exploring cerebral and cardiac organoids

Current organoid research has a shortfall of physiological cell types, despite being promising for drug development.

From ACROBiosystems 27 Jan 2025

Using cerebral organoids as neuroinflammation models

Using cerebral organoids as neuroinflammation models

Drug development for neurological disorders faces high clinical failure because of efficacy problems.

From ACROBiosystems 27 Jan 2025

iPSC-derived organoids for organ-specific disease modeling

iPSC-derived organoids for organ-specific disease modeling

Discover how iPSC-derived organoids can be used for toxicity screening and organ-specific disease modeling.

From ACROBiosystems 27 Jan 2025

E.coli DNA testing to support CGT development

E.coli DNA testing to support CGT development

This article explores high-sensitivity E.coli DNA testing to provide support for CGT development.

From ACROBiosystems 27 Jan 2025

Design and development of target proteins in drug discovery

Design and development of target proteins in drug discovery

Target proteins play a key role in the antibody process, and play a fundamental part of drug discovery.

From ACROBiosystems 27 Jan 2025

Raw material considerations for CGT

Raw material considerations for CGT

Learn what considerations you need to take into account for successful CGT and other biologics.

From ACROBiosystems 27 Jan 2025

Scalable protocols for T cell activation

Scalable protocols for T cell activation

As immunotherapy has advanced, treatment approaches have also evolved making protocols for T cell activation more important than ever.

From ACROBiosystems 27 Jan 2025

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.